Incorporating Cascade Effects of Genetic Testing in Economic Evaluation: A Scoping Review of Methodological Challenges

by Alexandra Cernat, Robin Z. Hayeems, Lisa A. Prosser, Wendy J. Ungar
Published 2021-04-01

Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States

by Shu-Fang Shih, Abram L. Wagner, Nina B. Masters, Lisa A. Prosser, Lisa A. Prosser, Yihan Lu, Brian J. Zikmund-Fisher, Brian J. Zikmund-Fisher
Published 2021-06-01

Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.

by Michael J Harvey, Lisa A Prosser, Mark L Messonnier, David W Hutton
Published 2016-01-01

Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness

by Huey-Fen Chen, Angela M. Rose, Susan Waisbren, Ayesha Ahmad, Lisa A. Prosser
Published 2021-05-01

Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease

by Lisa A. Prosser, K. K. Lam, Scott D. Grosse, Mia Casale, Alex R. Kemper
Published 2018-04-01

Cost-effectiveness of the Adaptive Implementation of Effective Programs Trial (ADEPT): approaches to adopting implementation strategies

by Andria B. Eisman, David W. Hutton, Lisa A. Prosser, Shawna N. Smith, Amy M. Kilbourne
Published 2020-12-01

Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events.

by Tara A Lavelle, Martin I Meltzer, Achamyeleh Gebremariam, Kara Lamarand, Anthony E Fiore, Lisa A Prosser
Published 2011-01-01

Health utilities and parental quality of life effects for three rare conditions tested in newborns

by Norma-Jean Simon, John Richardson, Ayesha Ahmad, Angela Rose, Eve Wittenberg, Brittany D’Cruz, Lisa A. Prosser
Published 2019-01-01

Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China.

by Zhuoying Huang, Xiaodong Sun, Abram L Wagner, Jia Ren, Matthew L Boulton, Lisa A Prosser, Brian J Zikmund-Fisher
Published 2018-01-01

The financial and time burden associated with phenylketonuria treatment in the United States

by Angela M. Rose, Scott D. Grosse, Sandra P. Garcia, Janice Bach, Mary Kleyn, Norma-Jean E. Simon, Lisa A. Prosser
Published 2019-12-01

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

by Lisa A Prosser, Tara A Lavelle, Anthony E Fiore, Carolyn B Bridges, Carrie Reed, Seema Jain, Kelly M Dunham, Martin I Meltzer
Published 2011-01-01

The role of severity perceptions and beliefs in natural infections in Shanghai parents’ vaccine decision-making: a qualitative study

by Xiaodong Sun, Zhuoying Huang, Abram L. Wagner, Lisa A. Prosser, Erzhan Xu, Jia Ren, Bei Wang, Wenlu Yan, Brian J. Zikmund-Fisher
Published 2018-06-01

Use of a choice survey to identify adult, adolescent and parent preferences for vaccination in the United States

by Tara A. Lavelle, Mark Messonnier, Shannon Stokley, David Kim, Aparna Ramakrishnan, Achamyeleh Gebremariam, Norma-Jean E. Simon, Angela M. Rose, Lisa A. Prosser
Published 2019-07-01

Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children

by Lisa A. Prosser, Carolyn Buxton Bridges, Timothy M. Uyeki, Virginia L. Hinrichsen, Martin I. Meltzer, Noelle-Angelique M. Molinari, Benjamin Schwartz, William W. Thompson, Keiji Fukuda, Tracy A. Lieu
Published 2006-10-01